|
 |
CEOS
The page is no longer available. You may want to read the following pages.
JR Erickson, BJ He, IM Grumbach... - Physiological ..., 2011 - Am Physiological Soc Abstract The multifunctional Ca 2+-and calmodulin-dependent protein kinase II (Ca MKII) is now recognized to play a central role in pathological events in the cardiovascular system. Ca MKII has diverse downstream targets that promote vascular disease, heart failure, and ...
SS Virani, DJ Catellier, LA Pompeii, V Nambi... - Atherosclerosis, 2011 - Elsevier Objective There is a paucity of data regarding relations of apolipoproteins (apolipoprotein B [Apo B] and apolipoprotein A-1 [Apo A-1]), lipoprotein particle measures (low-density lipoprotein particle concentration [LDLp] and high-density lipoprotein particle ...
FK Gould, DW Denning, TSJ Elliott... - Journal of ..., 2011 - Br Soc Antimicrob Chemo Abstract The BSAC guidelines on treatment of infectious endocarditis (IE) were last published in 2004. The guidelines presented here have been updated and extended to reflect developments in diagnostics, new trial data and the availability of new antibiotics. ...
R Wang, W Hu... - Journal of Investigative Medicine, 2012 - Objective: Previous studies demonstrated that G1359A polymorphism of cannabinoid receptor-1 (CNR1) was associated with cardiovascular risk factors including obesity, insulin resistance, dyslipidemia, and inflammation, which are also risk factors for developing type ... [HTML]
F Spillmann, S Van Linthout... - Endocrine, metabolic & ..., 2012 - Diabetic cardiopathy includes a specific cardiomyopathy, which occurs in the absence of coronary heart disease and hypertension under diabetes mellitus. Hyperglycemia, hyperinsulinemia, and hyperlipidemia, characteristic metabolic disturbances evident in ...
|
|
|
